Pyoderma Gangrenosum: An Update - 15/08/11
, J. Mark Jackson, MDAbstract |
Pyoderma gangrenosum (PG) can be differentiated into classic and atypical forms. The classic form is characterized by ulcers and the atypical form by deep erosions with bullous blue-gray margins. Pathergy, the development of cutaneous lesions at sites of trauma, is a common feature of both forms of PG. Approximately 50% of patients who have PG have underlying systemic diseases, most commonly inflammatory bowel disease, myeloproliferative disorders, and various forms of inflammatory arthritis. The diagnosis of PG is one of exclusion. The management of this disorder begins with treatment of any underlying disease and local or systemic glucocorticoids or immunomodulating therapies.
Le texte complet de cet article est disponible en PDF.Plan
| Dr. Jackson has received funding for research, honoraria, consulting, and/or other support from the following companies: 3M, Abbott, Amgen, Biogen, Centocor, CollaGenex, Connetics, Ferndale, Galderma, Genentech, Novartis, and Roche. Dr. Callen has received honoraria, consulted for, or served as a safety monitor for Amgen, Abbott, Centocor, Genmab, Electrical Optical Sciences, and Stiefel. |
Vol 33 - N° 4
P. 787-802 - novembre 2007 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
